Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,500
Closed -$11.6K 13586
2025
Q4
$11.6K Buy
+11,500
New +$14.3K ﹤0.01% 12042
2023
Q4
Sell
-16,500
Closed -$49.2K 12778
2023
Q3
$49.2K Buy
16,500
+6,100
+59% +$23.2K ﹤0.01% 11314
2023
Q2
$46.4K Buy
+10,400
New +$46.6K ﹤0.01% 11367
2022
Q4
Sell
-10,600
Closed -$28K 12981
2022
Q3
$28K Buy
+10,600
New +$23.9K ﹤0.01% 12471
2022
Q1
Sell
-42,300
Closed -$201K 13447
2021
Q4
$201K Sell
42,300
-47,400
-53% -$191K ﹤0.01% 11436
2021
Q3
$232K Buy
89,700
+7,200
+9% +$19K ﹤0.01% 11165
2021
Q2
$245K Buy
82,500
+53,700
+186% +$178K ﹤0.01% 11183
2021
Q1
$112K Buy
+28,800
New +$147K ﹤0.01% 11801
2020
Q3
Sell
-74,100
Closed -$340K 10806
2020
Q2
$340K Buy
+74,100
New +$481K ﹤0.01% 8137

Other funds holding IFRX

Jeff Yass's IFRX Position: Q2 2026 in Review

Jeff Yass reduced its InflaRx (IFRX) stake by 45% in Q2 2026, selling an estimated $64.5K and leaving 42,784 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #12526.

Jeff Yass first reported a position in IFRX in Q2 2020 and has held it in 20 quarters since. The position peaked at $795K in Q2 2023. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Jeff Yass held 42,784 shares of InflaRx worth $95.8K as of Q2 2026.
  • Jeff Yass sold 34,330 InflaRx shares in Q2 2026, an estimated $64.5K.
  • InflaRx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12526 holding.
  • Jeff Yass first reported a position in InflaRx in Q2 2020 and has held it in 20 quarters since.
  • Jeff Yass's InflaRx position peaked at $795K in Q2 2023.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.